Kaskela Law LLC is investigating Halozyme Therapeutics, Inc. (“Halozyme”) (NASDAQ: HALO) on behalf of the company’s shareholders.

The investigation seeks to determine whether Halozyme and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s investors in connection with recent corporate actions.

Halozyme shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options. 

CONTACT:

KASKELA LAW LLC
Seamus Kaskela, Esq.
([email protected])
Adrienne Bell, Esq.
([email protected])
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750